Dr Kate Coleman, BSc PhD FRCS FRCophth
iKey CEO and Founder, Dr Kate Coleman, is a former Consultant Ophthalmic surgeon at Blackrock Clinic and Mount Carmel Hospital in Dublin. She has lectured in Ophthalmology to medical students at the Royal College of Surgeons in Ireland, to Optometry students at Dublin Institute of Technology and taught Oculoplastic surgery at Beaumont hospital, Dublin.
Dr Coleman is the founder of Right to Sight, a social enterprise combating preventable blindness in eight countries in Africa. In 2019, Dr Coleman was awarded a Leadership Medal by the Royal College of Surgeons in honour of her work as founder of Right to Sight which is now run from Norway and empowered by Rotary in Kenya.
She is a leading expert in the use of Botulinum Toxin in Oculoplastic conditions and is the author of internationally recognised textbooks on the subject.
Watch her 2009 TED talk discussing global needless blindness here.
Mr Peter McManamon
Peter co-founded Parthus Technologies plc (now CEVA Inc.) in 1993. He was Chief Financial Officer from 1993 to 2001 and EVP, Corporate Development responsible for significant merger and acquisition activity from January 2001 to October 2002. He is currently Chairman of the board of directors of CEVA Inc., a NASDAQ and London listed company,
Since 2003, Peter has been a member of the Board of the National Development Finance Agency (NDFA), an appointment made by the Irish Government and is also a member of the Audit Committee at the National Treasury Management Agency (NTMA). Peter is a member of the Executive Committee of the Irish Software Association and a member of the Governing Board of ICT Ireland.
Peter is also a Chartered Director and a member of the Institute of Directors in Ireland and a Business Advisor on the Stanford University Executive Program, Strategic Leadership for CFOs, which is funded by Enterprise Ireland.
Dr. Mary Aiken
Dr.Mary Aiken is a cyberpsychologist and Adjunct Associate Professor at the Geary Institute for Public Policy, University College Dublin. She is a lecturer in Criminology and Research Fellow at the School of Law, Middlesex University, Fellow of the Society for Chartered IT Professionals and a Global Fellow at the Wilson Center, a leading US institution for in-depth research and dialogue to inform actionable ideas on global issues.She is an Advisor to Europol’s Cyber Crime Centre (EC3), member of the INTERPOL Specialists Group for Crimes against Children, and sits on the advisory board of the Hague Justice Portal Peace, Justice & Security Foundation. Mary is the former Director of the RCSI Cyberpsychology Research Centre at the Royal College of Surgeons in Ireland.
Mary has advised at national and European level in policy debates at the intersection of technology and human behaviour and has published and spoken internationally on this topic. Her current research interests include Internet psychology, AI, human factors in cybersecurity, Healthtech, cyber behavioural profiling, behavioural manipulation online, youth protection and age verification online, along with the impact of technology on the developing child.
In 2016 Mary was named as one of the top 50 most inspiring women in technology in Europe. In 2017 she was inducted into the Infosecurity Europe Hall of Fame, in recognition of her contribution to the information and cybersecurity sector. In 2018 she led the campaign for a Digital Age of Consent of 16. Marys work as a cyberpsychologist inspired the CBS primetime television series CSI: Cyber. Her recent book, ‘The Cyber Effect’ was selected by the Times as a ‘book of the year’ in the Thought category, and was listed in the 2016 top twenty science books by Nature the International Journal of Science.
Professor David Keegan
Prof David Keegan MB BCh BAO; LRCP&SI. MMedSc (Anat); FRCSI(Oph); FRCOphth; Ph UCD Clinical Professor of Ophthalmology and Retina, UCD School of Medicine, University College DublinConsultant Vitreo-Retinal Surgeon and Head of Department at the Mater Misericordiae University Hospital Honorary Consultant Vitreo-retinal surgeon at Temple Street Children’s Hospital.National Clinical Lead for Diabetic Retinopathy Screening, National Screening Service, NSS, DublinChair of Low Vision Working Group, European Reference Network (ERN)for Rare Eye Disease
Professor Keegan is a graduate of the Royal College of Surgeons in Ireland (RCSI) qualifying in 1994.He attained his Masters degree in Anatomy from University College Dublin in 1996. He completed his Basic and Higher Surgical Training at Moorfield’s Eye Hospital, London (1997-2005) and followed that with a Fellowship in Complex Vitreo-retinal Surgery Columbia University / New York Presbyterian Hospital, New York, USA (2005-2006) with Dr Stanley Chang. During that time (1999-2002) he completed his PhD studies and did clinical fellowship placements with Prof Alan Bird in Age Related Macular Degeneration (AMD) and Inherited Retinal Disease (IRD). He attained his PhD from the Institute of Ophthalmology / University College London (Retinal Transplantation: supervised by Ray Lund). He continued his work on retinal transplantation in Ireland concentrating on the role of the innate immune system in sub-retinal transplant loss.He specializes in medical and surgical retinal disease. This includes AMD, IRD, diabetes and retinal surgery including macular conditions, proliferative vitreo-retinopathy, paediatric retinal surgery and diabetic retinal disease. In 2013 Prof Keegan was appointed National Clinical Lead for the Diabetic Retinopathy Screening Programme which is a government-funded screening programme in Ireland that offers free, regular diabetic retinopathy screening to people with diabetes aged 12 years and older. He is currently Head of Department of Ophthalmology at the Mater hospital Dublin. He also runs the Mater Multidisciplinary Inherited Retinal Degeneration and Diabetic Retinal Treatment Services along with the Retinal Clinical Trials Unit (Mater Retina Research Group). The unit is a member of the European Vision Institute Clinical Research Network (EVICR.net) The team have developed enhanced retinal imaging (adaptive optics) in Ireland in collaboration with Dr Vohnsen at UCD.They have conducted multiple trials in retinal disease (macular degeneration, diabetic retinopathy and inherited retinal degeneration) including the design and implementation of the Phase 1 trial of the injectable intraocular telescope (WANG) with VisionCareTM.
Collaborations Include:Professor Jane Farrar, Trinity College School of Genetics;Dr Paul Kenna, Royal Victoria Eye and Ear Hospital; Dublin Ms Guliana Silvestri, Belfast Trust, Belfast; Professor Bala Ambati, Moran Eye Centre, Utah USA ;Dr Brian Vohnsen, Dept of Physics, UCD. He serves on the Board of both the National Council of the Blind Ireland and Fighting Blindness Ireland. He Chairs the Low Vision Working Group and sits on the co-ordinating committee of the European Reference Network for Rare Eye Disease group (ERN-EYE).
Dr. Catherine Mooney
Dr. Mooney is assistant Professor and lecturer at UCD Department of Computer Science. Her research combines cutting-edge computational and biomedical techniques to efficiently integrate multiple data types into a single biomarker, including cancer biomarker research. She attained her doctorate in Protein Structure Prediction using Bidirectional Recurrent Neural Networks (BRNN). Since then her postdoctoral research involved development of web servers for short linear motif and peptide property prediction (bioware.ucd.ie). This software has been utilised in collaborations with industry, including the Enterprise Ireland-funded industry-academia partnership with the Irish food industry, Food for Health Ireland (FHI), and through data analysis work carried out for a US-based cosmetics company.
Non mydriatic fundus cameras